Corporate Board members face even more risks in today’s aggressive FCPA enforcement environment. They have adjusted to the new post-Sarbanes-Oxley environment. Today, they face the perils of FCPA enforcement. As the Justice Department and the SEC bear down on more and more companies, Board members have to be even more sensitive and careful when it comes to FCPA enforcement. If you read between the lines...

 Richard Alderman The legal marketing hysteria surrounding the UK Bribery Act is entertaining and surreal. Article after article, pitch after pitch focuses on the new D-Day: July 1, the effective date for the UK Bribery Act. Lawyers and commentators are trying to scare global companies into acting quickly to design and implement new compliance policies, or face the wrath of prosecutorial zeal. These claims...

 Richard Alderman The legal marketing hysteria surrounding the UK Bribery Act is entertaining and surreal. Article after article, pitch after pitch focuses on the new D-Day: July 1, the effective date for the UK Bribery Act. Lawyers and commentators are trying to scare global companies into acting quickly to design and implement new compliance policies, or face the wrath of prosecutorial zeal. These claims...

 Richard Alderman The legal marketing hysteria surrounding the UK Bribery Act is entertaining and surreal. Article after article, pitch after pitch focuses on the new D-Day: July 1, the effective date for the UK Bribery Act. Lawyers and commentators are trying to scare global companies into acting quickly to design and implement new compliance policies, or face the wrath of prosecutorial zeal. These claims...

 Richard Alderman The legal marketing hysteria surrounding the UK Bribery Act is entertaining and surreal. Article after article, pitch after pitch focuses on the new D-Day: July 1, the effective date for the UK Bribery Act. Lawyers and commentators are trying to scare global companies into acting quickly to design and implement new compliance policies, or face the wrath of prosecutorial zeal. These claims...

 Richard Alderman The legal marketing hysteria surrounding the UK Bribery Act is entertaining and surreal. Article after article, pitch after pitch focuses on the new D-Day: July 1, the effective date for the UK Bribery Act. Lawyers and commentators are trying to scare global companies into acting quickly to design and implement new compliance policies, or face the wrath of prosecutorial zeal. These claims...

One area where compliance officers and practitioners need to focus is on the requisite intent for a criminal violation. For compliance officers facing difficult policy choices on FCPA compliance policies, the touchstone of such policies should be the employee’s intent — was it criminal, negligent or benign?  It is one thing to have a policy which requires prior approval for any gift to a foreign...

The World Compliance FCPA Tour lands in our Nation’s Capitol on May 12, 2011, at the Grand Hyatt in Washington, D.C. Join me, Dick Cassin, owner of the FCPA Blog, and Ryan Morgan, World Compliance’s FCPA Specialist for an informative presentation and discussion on FCPA, UK Anti-Bribery and Compliance issues. The event is FREE and information is HERE.

The World Compliance FCPA Tour lands in our Nation’s Capitol on May 12, 2011, at the Grand Hyatt in Washington, D.C. Join me, Dick Cassin, owner of the FCPA Blog, and Ryan Morgan, World Compliance’s FCPA Specialist for an informative presentation and discussion on FCPA, UK Anti-Bribery and Compliance issues. The event is FREE and information is HERE.

The criminal trial of Lauren Stevens, Glaxo’s vice president and in-house counsel, begins tomorrow. There is a lot at stake besides the liberty of Lauren Stevens. The government claims that Stevens made false statements and obstructed justice in responding to the FDA’s informal inquiry letter in an off-label marketing investigation. Stevens claims she merely repeated information given to her by in-house and outside counsel, and...